Augmedix
Stock Forecast, Prediction & Price Target
Augmedix Financial Estimates
Augmedix Revenue Estimates
Augmedix EBITDA Estimates
Augmedix Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $22.16M N/A | $30.93M 39.55% | $44.85M 45.00% | Avg: $66.57M Low: $62.54M High: $72.36M avg. 48.42% | Avg: $62M Low: $58.24M High: $67.38M avg. -6.87% | ||
Net Income
% change YoY
| $-17.16M N/A | $-26.52M -54.58% | $-19.17M 27.73% | Avg: $-25.71M Low: $-22.41M High: $-19.33M avg. -34.14% | Avg: $-15.38M Low: $-17.11M High: $-14.17M avg. 40.18% | ||
EBITDA
% change YoY
| $-17.93M N/A | $-22.37M -24.71% | $-17.68M 20.96% | Avg: $-50.03M Low: $-54.38M High: $-47.00M avg. -182.96% | Avg: $-46.59M Low: $-50.64M High: $-43.77M avg. 6.87% | ||
EPS
% change YoY
| -$0.59 N/A | -$0.71 -20.33% | -$0.44 38.02% | Avg: -$0.48 Low: -$0.51 High: -$0.44 avg. -8.33% | Avg: -$0.35 Low: -$0.39 High: -$0.32 avg. 26.57% | ||
Operating Expenses
% change YoY
| $27.94M N/A | $36.32M 29.98% | $40.30M 10.95% | Avg: $59.22M Low: $55.63M High: $64.36M avg. 46.93% | Avg: $55.14M Low: $51.81M High: $59.94M avg. -6.87% | ||
FAQ
What is Augmedix stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 3.02% in 2025-2026.
We have gathered data from 3 analysts. Their low estimate is -22.41M, average is -25.71M and high is -19.33M.
What is Augmedix stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 20.77% in 2025-2026.
We have gathered data from 3 analysts. Their low revenue estimate is $62.54M, average is $66.57M and high is $72.36M.
What is Augmedix stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 9.11% in 2025-2026.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$0.51, average is -$0.48 and high is $-0.44.
What is the best performing analyst?
In the last twelve months analysts have been covering Augmedix stock. The most successful analyst is Elizabeth Anderson.